Skip to main content
. Author manuscript; available in PMC: 2016 Aug 15.
Published in final edited form as: Int J Cancer. 2015 Feb 2;137(4):826–836. doi: 10.1002/ijc.29441

Figure 2.

Figure 2

CCL22 levels by case/control status within CD4 groupings. Samples were divided into three groups according to CD4 counts/µL (<200, 200–499, >=500), CCL22 levels (ng/mL) were compared in cases and controls of each group, UCSF Adult Glioma Study 2010–2012. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]